Spyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYRE and other ETFs, options, and stocks.About SYRE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
SYRE Key Statistics
Stock Snapshot
With a market cap of 7.71B, Spyre Therapeutics(SYRE) trades at $89.00. The stock has a price-to-earnings ratio of -37.66.
On 2026-07-01, Spyre Therapeutics(SYRE) shares started trading at $90.14, with intraday highs of — and lows of —.
Trading activity shows a volume of 365, compared to an average daily volume of 2.48M.
The stock's 52-week range extends from a low of $14.00 to a high of $102.06.
The stock's 52-week range extends from a low of $14.00 to a high of $102.06.
Analyst ratings
100%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.